Back
Madrigal Pharmaceuticals Vs. Intra-Cellular Therapies Industry Stock Comparison
Buy
71
MDGL
Madrigal Pharmaceuticals
Last Price:
259.70
Seasonality Move:
31.67%
Buy
54
ITCI
Intra-Cellular Therapies
Last Price:
84.64
Seasonality Move:
25.32%
Buy
71
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Intra-Cellular Therapies (ITCI)
is a Buy
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $84.75. The Score for ITCI is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ITCI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $259.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $84.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 74.74 | Buy |
| Chaikin Money Flow: | 898979 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.29 - 223.91) | Buy |
| Bollinger Bands (100): | (221.8 - 277.54) | Buy |
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.86 | Buy |
| Relative Strength Index (14 RSI): | 71.95 | Buy |
| Chaikin Money Flow: | -881648 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.93 - 78.75) | Buy |
| Bollinger Bands (100): | (71.47 - 77.97) | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 216.22 | Buy |
| 20-day SMA: | 214.16 | Buy |
| 50-day SMA: | 227.04 | Buy |
| 200-day SMA: | 240.71 | Buy |
| 8-day EMA: | 223.2 | Buy |
| 20-day EMA: | 218.42 | Buy |
| 50-day EMA: | 226.38 | Buy |
| 200-day EMA: | 233.63 | Buy |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 78.42 | Buy |
| 20-day SMA: | 75.93 | Buy |
| 50-day SMA: | 74.9 | Buy |
| 200-day SMA: | 71.73 | Buy |
| 8-day EMA: | 79.67 | Buy |
| 20-day EMA: | 77.15 | Buy |
| 50-day EMA: | 75.58 | Buy |
| 200-day EMA: | 71.3 | Buy |
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.93 per share, and an increase next year of $1.08 per share.
Madrigal Pharmaceuticals Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intra-Cellular Therapies Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||